ACAT1 and neoplasm: Moreover, the tumor cells will stabilize this vital ketolytic entry because ACAT1 tetramers acquire an acetylation capability, capable of further acetylating and inhibiting the PDH entry, which is already inhibited by phosphorylation; this closes the glycolytic entry in the citric acid cycle and strengthens the ketolytic dependency of the tumor cell [8].